US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 31.633
  • +0.613+1.97%
Trading Feb 18 09:50 ET
1.52BMarket Cap10.51P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amphastar Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 177.957M--
--2024/Q4-- / 188.777M--
Nov 6, 20242024/Q3191.214M / 194.693M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 177.957M--
--2024/Q4-- / 188.777M--
Nov 6, 20242024/Q3191.214M / 194.693M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--

Unlock Free Earnings Estimates

Amphastar Pharmaceuticals Earnings Reports

  • Amphastar Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:29 ET

  • Amphastar Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 16:20 ET

  • Amphastar Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 10, 2024 15:05 ET

  • Amphastar Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 29, 2024 22:45 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Constellation Brands
    STZ
    +5.41%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +4.97%
    Lantheus
    LNTH
    +3.06%
    DexCom
    DXCM
    +2.47%
    New Fortress Energy
    NFE
    +1.93%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 14, 2025

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data